Annabel Samimy
Stock Analyst at Stifel
(3.38)
# 940
Out of 4,868 analysts
56
Total ratings
41.67%
Success rate
26.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Annabel Samimy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Initiates: Buy | $143 | $114.64 | +24.74% | 1 | Apr 10, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $21.00 | +114.29% | 1 | Mar 26, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $50 | $21.62 | +131.27% | 1 | Jan 8, 2025 | |
| ALT Altimmune | Initiates: Buy | $18 | $6.78 | +165.49% | 1 | Jan 8, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $17 | $3.36 | +406.10% | 4 | Nov 22, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $40 | $10.28 | +289.11% | 1 | Oct 8, 2024 | |
| KMDA Kamada | Initiates: Buy | $18 | $7.22 | +149.31% | 1 | Jul 3, 2024 | |
| PHAT Phathom Pharmaceuticals | Initiates: Buy | $24 | $10.90 | +120.18% | 1 | May 3, 2024 | |
| RGNX REGENXBIO | Maintains: Buy | $40 | $8.57 | +366.74% | 2 | Apr 12, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $80 | $26.28 | +204.41% | 6 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $230 | $108.24 | +112.49% | 8 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $25 | $9.30 | +168.96% | 1 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.48 | +79.67% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $65 | $17.76 | +265.99% | 3 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $28 → $11 | $5.16 | +113.18% | 4 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $13.74 | +227.63% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $0.79 | +912.66% | 1 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.51 | +4,624.41% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $20 | $29.64 | -32.52% | 1 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $750 | $1.08 | +69,344.44% | 3 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $24 | $32.96 | -27.18% | 7 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $21 | $0.66 | +3,097.81% | 6 | Sep 18, 2019 |
Ligand Pharmaceuticals
Apr 10, 2025
Initiates: Buy
Price Target: $143
Current: $114.64
Upside: +24.74%
Palvella Therapeutics
Mar 26, 2025
Initiates: Buy
Price Target: $45
Current: $21.00
Upside: +114.29%
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $21.62
Upside: +131.27%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $6.78
Upside: +165.49%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20 → $17
Current: $3.36
Upside: +406.10%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $10.28
Upside: +289.11%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $7.22
Upside: +149.31%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $10.90
Upside: +120.18%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $8.57
Upside: +366.74%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $26.28
Upside: +204.41%
Mar 15, 2024
Maintains: Buy
Price Target: $225 → $230
Current: $108.24
Upside: +112.49%
Mar 8, 2024
Reiterates: Buy
Price Target: $23 → $25
Current: $9.30
Upside: +168.96%
Oct 5, 2023
Initiates: Buy
Price Target: $35
Current: $19.48
Upside: +79.67%
Aug 29, 2023
Maintains: Buy
Price Target: $60 → $65
Current: $17.76
Upside: +265.99%
Jun 26, 2023
Downgrades: Hold
Price Target: $28 → $11
Current: $5.16
Upside: +113.18%
Mar 7, 2023
Initiates: Buy
Price Target: $45
Current: $13.74
Upside: +227.63%
Nov 10, 2022
Upgrades: Buy
Price Target: $8
Current: $0.79
Upside: +912.66%
Aug 24, 2021
Initiates: Buy
Price Target: $24
Current: $0.51
Upside: +4,624.41%
Apr 24, 2020
Initiates: Hold
Price Target: $20
Current: $29.64
Upside: -32.52%
Apr 16, 2020
Maintains: Buy
Price Target: $700 → $750
Current: $1.08
Upside: +69,344.44%
Apr 16, 2020
Maintains: Hold
Price Target: $25 → $24
Current: $32.96
Upside: -27.18%
Sep 18, 2019
Maintains: Hold
Price Target: $15 → $21
Current: $0.66
Upside: +3,097.81%